Protocol W: Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk Protocol AA: Peripheral Diabetic Retinopathy Lesions on Ultrawide-f Read More

PANORAMA 1411: A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients with Moderately Severe to Severe Nonproliferative Diabetic Re Read More

Sponsor: Genentech A phase I/II, open-label, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.3 mg ranibizumab given monthly c Read More

Sponsor: JAEB Center for Health Research-DRCR Effects of Diabetes Education during Retinal Ophthalmology Visits on Diabetes Control Read More

Sponsor: JAEB Center for Health Research-DRCR A Comparative Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Read More

Sponsor: Regeneron Title: A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Mac Read More

Diabetic Retinopathy Clinical Research Network: Effect of Diabetes Education during Retinal Ophthalmology Visits on Diabetes Control. Protocol M Read More